TOPIC

Focus

Focus
SCMP gets to the heart of the matter with its in-depth analysis on the pressing issues in Hong Kong and around the world.
United States

Are Chinese biotechs what the doctor ordered as Big Pharma faces ‘patent cliff’?

US drug makers are racing to plug looming ‘patent cliff’ revenue gaps – and increasingly they are turning to China biotechs.

From taboo to trendy: China’s second-hand luxury market cashes in on resale boom

Why China’s rapid military build-up is ‘hardly the whole story’

The PLA has been moving fast to modernise its arsenal and warfare strategy, but it’s seen as ‘seriously deficient’ in some areas.

Advertisement
Advertisement
Advertisement
Help preserve 120 years of quality journalism.
SUPPORT NOW
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement